Clinical Trial Update: Allergic Rhinitis Combination Pharmacotherapy Efficacy Study [Phase 4]

View source ↗

Summary

Phase 4 clinical trial for allergic rhinitis combination pharmacotherapy was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Snippet

Sponsor: St. Paul's Sinus Centre | Conditions: Allergic Rhinitis | Phase 4 | Status: WITHDRAWN